|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.993
|
Mouse |
|
|
chromatin organization
|
GO:0006325 |
206 |
0.986
|
Mouse |
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.958
|
Worm |
|
|
chromatin modification
|
GO:0016568 |
187 |
0.951
|
Mouse |
|
|
dna alkylation
|
GO:0006305 |
43 |
0.927
|
Mouse |
|
|
dna methylation
|
GO:0006306 |
43 |
0.895
|
Mouse |
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.885
|
Mouse |
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.863
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.836
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.834
|
Mouse |
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.816
|
Mouse |
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.797
|
Worm |
|
|
dna modification
|
GO:0006304 |
50 |
0.707
|
Mouse |
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.635
|
Worm |
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.632
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.621
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.555
|
Mouse |
|
|
membrane tubulation
|
GO:0097320 |
4 |
0.537
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.503
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.497
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.483
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.435
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.432
|
Worm |
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.432
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.427
|
Mouse |
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.416
|
Mouse |
|
|
endocytosis
|
GO:0006897 |
168 |
0.394
|
Worm |
|
|
dna repair
|
GO:0006281 |
107 |
0.386
|
|
|
|
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
|
GO:1901030 |
6 |
0.382
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.373
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.354
|
|
|
|
mitochondrial outer membrane permeabilization involved in programmed cell death
|
GO:1902686 |
11 |
0.350
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.344
|
Worm |
|
|
positive regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902110 |
11 |
0.337
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.317
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.313
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.312
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.293
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.290
|
|
|
|
phosphatidic acid biosynthetic process
|
GO:0006654 |
2 |
0.287
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.280
|
Human |
|
|
wound healing
|
GO:0042060 |
157 |
0.268
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.267
|
Human Worm |
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.258
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.250
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.248
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.246
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.243
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.243
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.235
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.234
|
Mouse |
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.232
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.229
|
Mouse |
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.222
|
Human |
|
|
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:0001844 |
4 |
0.222
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.222
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.217
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.209
|
Worm |
|
|
inner cell mass cell proliferation
|
GO:0001833 |
15 |
0.208
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.207
|
|
|
|
positive regulation of mitochondrion organization
|
GO:0010822 |
17 |
0.202
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.199
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.195
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.192
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.191
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.187
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.184
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.178
|
Mouse |
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.178
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.175
|
|
|
|
olfactory nerve development
|
GO:0021553 |
3 |
0.174
|
|
|
|
locomotor rhythm
|
GO:0045475 |
8 |
0.174
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.174
|
Mouse |
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.167
|
Worm |
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.165
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.165
|
Worm |
|
|
compound eye development
|
GO:0048749 |
1 |
0.165
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.163
|
Mouse |
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.162
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.158
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.156
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.156
|
Mouse |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.154
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.152
|
Human Worm |
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.152
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.149
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.148
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.148
|
Worm |
|
|
mitochondrial membrane organization
|
GO:0007006 |
26 |
0.147
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.147
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.146
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.146
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.145
|
Worm |
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.144
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.141
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.140
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.140
|
Human |
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.139
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.138
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.138
|
|
|
|
primitive erythrocyte differentiation
|
GO:0060319 |
3 |
0.137
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
27 |
0.136
|
|
|
|
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:1900740 |
3 |
0.136
|
|
|
|
positive regulation of g2 m transition of mitotic cell cycle
|
GO:0010971 |
5 |
0.136
|
Mouse |
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.135
|
|
|
|
circadian behavior
|
GO:0048512 |
13 |
0.134
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.133
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.132
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.130
|
|
|
|
ectodermal cell differentiation
|
GO:0010668 |
3 |
0.130
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.129
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.128
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.128
|
|
|
|
tricuspid valve development
|
GO:0003175 |
3 |
0.128
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.126
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.124
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.123
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.122
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.121
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.119
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.116
|
Worm |
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.116
|
Mouse |
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.112
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.109
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.109
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.109
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.107
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.107
|
|
|
|
regulation of membrane permeability
|
GO:0090559 |
18 |
0.106
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.106
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.106
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.106
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.106
|
Human |
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.106
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.104
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.103
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.103
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.103
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.102
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.098
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.098
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.098
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.096
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.096
|
|
|
|
regulation of mitochondrial membrane permeability
|
GO:0046902 |
17 |
0.094
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.094
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.093
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.093
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.092
|
|
|
|
protein insertion into mitochondrial membrane
|
GO:0051204 |
4 |
0.092
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.091
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.091
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.090
|
Worm |
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.090
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.089
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.088
|
Worm |
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.088
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.088
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.088
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.087
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.087
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.087
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.086
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.085
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.085
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.084
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.084
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.084
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.084
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.083
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.081
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.081
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.081
|
Human |
|
|
digestive tract development
|
GO:0048565 |
190 |
0.080
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.080
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.080
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.080
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.080
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.080
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.080
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.079
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.079
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.077
|
Mouse |
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.077
|
Mouse |
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.077
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.076
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.076
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.075
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.075
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.074
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.074
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.073
|
|
|
|
histone h2a ubiquitination
|
GO:0033522 |
3 |
0.073
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.072
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.071
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.071
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.070
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.070
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.070
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.070
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.069
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.069
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.069
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.069
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.069
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.069
|
Mouse |
|
|
organ growth
|
GO:0035265 |
117 |
0.068
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.068
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.068
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.067
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.067
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.066
|
|
|
|
histone h2a monoubiquitination
|
GO:0035518 |
1 |
0.066
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.066
|
|
|
|
atp dependent chromatin remodeling
|
GO:0043044 |
9 |
0.066
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.065
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.065
|
Worm |
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.065
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.064
|
Mouse |
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.064
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.064
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.063
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.063
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.062
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.062
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.062
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.062
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.060
|
Rat |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.060
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
12 |
0.060
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.060
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.059
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.059
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.058
|
Worm |
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.058
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.058
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.058
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.058
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.058
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.057
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.057
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.057
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.057
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.057
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.056
|
|
|
|
regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902108 |
14 |
0.056
|
|
|
|
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis
|
GO:0072309 |
3 |
0.056
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.056
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.056
|
|
|
|
synaptic vesicle recycling
|
GO:0036465 |
19 |
0.055
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.055
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.054
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.054
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.053
|
|
|
|
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
|
GO:1901028 |
7 |
0.053
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.053
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.052
|
Mouse |
|
|
digestive system development
|
GO:0055123 |
200 |
0.052
|
|
|
|
negative regulation of posttranscriptional gene silencing
|
GO:0060149 |
1 |
0.052
|
|
|
|
methylation dependent chromatin silencing
|
GO:0006346 |
6 |
0.051
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.051
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.051
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.051
|
|
|
|
mitochondrial outer membrane permeabilization
|
GO:0097345 |
10 |
0.051
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.051
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.050
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.050
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.050
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.050
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.050
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.050
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.049
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.049
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.049
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.049
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.049
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.049
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.049
|
|
|
|
protein folding
|
GO:0006457 |
28 |
0.048
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.048
|
Mouse |
|
|
positive regulation of mitochondrial membrane permeability
|
GO:0035794 |
12 |
0.048
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.048
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.047
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.047
|
Human |
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.047
|
Human |
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.046
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.046
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.046
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.045
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.045
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.045
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.045
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.045
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.044
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.044
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.044
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.044
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.043
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.043
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.043
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.043
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.042
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.042
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.042
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.042
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.042
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.042
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.042
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.042
|
|
|
|
rhythmic behavior
|
GO:0007622 |
15 |
0.042
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.042
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.041
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.041
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.041
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.041
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.041
|
|
|
|
eyelid development in camera type eye
|
GO:0061029 |
9 |
0.041
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.041
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.041
|
Worm |
|
|
regulation of interleukin 4 biosynthetic process
|
GO:0045402 |
3 |
0.040
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.040
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.040
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.040
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.039
|
Human |
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.039
|
Mouse |
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.039
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.039
|
|
|
|
regulation of antimicrobial peptide production
|
GO:0002784 |
1 |
0.039
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.039
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.039
|
|
|
|
synaptic vesicle endocytosis
|
GO:0048488 |
19 |
0.039
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.038
|
Worm |
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.038
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.038
|
Worm |
|
|
skin development
|
GO:0043588 |
220 |
0.038
|
Worm |
|
|
tube closure
|
GO:0060606 |
91 |
0.038
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.038
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.038
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.038
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.037
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.037
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.037
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.037
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.037
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.037
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.036
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.036
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.036
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.036
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.036
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.036
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.036
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.036
|
|
|
|
protein localization to mitochondrion
|
GO:0070585 |
15 |
0.036
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.036
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.036
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.035
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.035
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.035
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.035
|
|
|
|
primitive hemopoiesis
|
GO:0060215 |
7 |
0.035
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.035
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.035
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.035
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.034
|
|
|
|
establishment of protein localization to mitochondrion
|
GO:0072655 |
11 |
0.034
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.034
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.034
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.034
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.034
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.034
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.034
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.034
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.034
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.033
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.033
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.033
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.033
|
|
|
|
mrna transcription
|
GO:0009299 |
4 |
0.033
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.033
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.032
|
Human |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.032
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.032
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.032
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
24 |
0.032
|
Worm |
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.032
|
Rat Worm |
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.032
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.032
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.032
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.031
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.031
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.031
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.031
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.031
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.031
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.031
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.031
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.031
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.031
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.031
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.031
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.031
|
Human |
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.031
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.031
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.031
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.031
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.030
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.030
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.030
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.030
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.030
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.030
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.030
|
Human |
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.030
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.029
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.029
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.029
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.029
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.029
|
|
|
|
de novo protein folding
|
GO:0006458 |
9 |
0.029
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.029
|
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
10 |
0.029
|
Mouse |
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.029
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.029
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.029
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.029
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.028
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.028
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.028
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.028
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.028
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.028
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.028
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.028
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.028
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.028
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.028
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.028
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.028
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.028
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.028
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.027
|
Worm |
|
|
habituation
|
GO:0046959 |
3 |
0.027
|
|
|
|
peptide biosynthetic process
|
GO:0043043 |
11 |
0.027
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.027
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.027
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.027
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.027
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.027
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.027
|
|
|
|
metanephric ascending thin limb development
|
GO:0072218 |
2 |
0.027
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.027
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.027
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.027
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.026
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.026
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.026
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.026
|
|
|
|
ascending thin limb development
|
GO:0072021 |
2 |
0.026
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.026
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.026
|
|
|
|
thick ascending limb development
|
GO:0072023 |
2 |
0.026
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.026
|
|
|
|
metanephric juxtaglomerular apparatus development
|
GO:0072206 |
1 |
0.026
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.026
|
Worm |
|
|
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:1900739 |
3 |
0.025
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.025
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.025
|
|
|
|
inner cell mass cell fate commitment
|
GO:0001827 |
2 |
0.025
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.025
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.025
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.025
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.025
|
Worm |
|
|
kidney development
|
GO:0001822 |
213 |
0.025
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.025
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.024
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.024
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.024
|
|
|
|
receptor internalization
|
GO:0031623 |
16 |
0.024
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.024
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.024
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.024
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.024
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.024
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.024
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.024
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.024
|
|
|
|
positive regulation of interferon gamma biosynthetic process
|
GO:0045078 |
4 |
0.024
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.023
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.023
|
Mouse |
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.023
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.023
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.023
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.023
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.023
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.023
|
|
